The first clinical trial conducted in Japan to evaluate BioBridge in the surgical treatment of lymphedema reached its endpoint.
Terumo Corporation announced that the first clinical trial conducted in Japan to evaluate the BioBridge Collagen Matrix in the surgical treatment of lymphedema reached its endpoint.
The study enrolled 21 patients across four clinical sites, and its final report is being prepared for PMDA submission.